These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17890437)

  • 1. Scanning the cystic fibrosis transmembrane conductance regulator gene using high-resolution DNA melting analysis.
    Montgomery J; Wittwer CT; Kent JO; Zhou L
    Clin Chem; 2007 Nov; 53(11):1891-8. PubMed ID: 17890437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes.
    Gundry CN; Vandersteen JG; Reed GH; Pryor RJ; Chen J; Wittwer CT
    Clin Chem; 2003 Mar; 49(3):396-406. PubMed ID: 12600951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetric snapback primers for scanning and genotyping of the cystic fibrosis transmembrane conductance regulator gene.
    Zhou L; Palais RA; Ye F; Chen J; Montgomery JL; Wittwer CT
    Clin Chem; 2013 Jul; 59(7):1052-61. PubMed ID: 23503723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of high-resolution melting (HRM) for mutation scanning of selected exons of the CFTR gene.
    Krenková P; Norambuena P; Stambergová A; Macek M
    Folia Biol (Praha); 2009; 55(6):238-42. PubMed ID: 20163773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Audrezet MP; Dabricot A; Le Marechal C; Ferec C
    J Mol Diagn; 2008 Sep; 10(5):424-34. PubMed ID: 18687795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.
    Chou LS; Lyon E; Wittwer CT
    Am J Clin Pathol; 2005 Sep; 124(3):330-8. PubMed ID: 16191501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution genotyping by amplicon melting analysis using LCGreen.
    Wittwer CT; Reed GH; Gundry CN; Vandersteen JG; Pryor RJ
    Clin Chem; 2003 Jun; 49(6 Pt 1):853-60. PubMed ID: 12765979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution.
    Zhou L; Wang L; Palais R; Pryor R; Wittwer CT
    Clin Chem; 2005 Oct; 51(10):1770-7. PubMed ID: 16189378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotyping efficiency of 2 primer sets and an unlabeled oligonucleotide probe for the p.Phe508del in exon 10 of the CFTR gene as determined with high-resolution melting analysis.
    Poulou M; Destouni A; Fylaktou I; Kanavakis E; Tzetis M
    Clin Chem; 2012 Oct; 58(10):1490-2. PubMed ID: 22896710
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling.
    Le Maréchal C; Audrézet MP; Quéré I; Raguénès O; Langonné S; Férec C
    Hum Genet; 2001 Apr; 108(4):290-8. PubMed ID: 11379874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequencing analysis of cystic fibrosis transmembrane conductance regulator gene identifies cystic fibrosis-associated variants in the Severe Asthma Research Program.
    Izquierdo ME; Marion CR; Moore WC; Raraigh KS; Taylor-Cousar JL; Cutting GR; Ampleford E; Hawkins GA; Zein J; Castro M; Denlinger LC; Erzurum SC; Fahy JV; Israel E; Jarjour NN; Mauger D; Levy BD; Wenzel SE; Woodruff P; Bleecker ER; Meyers DA; Ortega VE
    Pediatr Pulmonol; 2022 Jul; 57(7):1782-1788. PubMed ID: 35451201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
    Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
    Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells.
    Valley HC; Bukis KM; Bell A; Cheng Y; Wong E; Jordan NJ; Allaire NE; Sivachenko A; Liang F; Bihler H; Thomas PJ; Mahiou J; Mense M
    J Cyst Fibros; 2019 Jul; 18(4):476-483. PubMed ID: 30563749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study.
    Dahl M; Tybjaerg-Hansen A; Lange P; Nordestgaard BG
    Respir Res; 2005 Oct; 6(1):113. PubMed ID: 16212675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tensin 1 (TNS1) is a modifier gene for low body mass index (BMI) in homozygous [F508del]CFTR patients.
    Walton NI; Zhang X; Soltis AR; Starr J; Dalgard CL; Wilkerson MD; Conrad D; Pollard HB
    Physiol Rep; 2021 Jun; 9(11):e14886. PubMed ID: 34086412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping.
    Herrmann MG; Durtschi JD; Wittwer CT; Voelkerding KV
    Clin Chem; 2007 Aug; 53(8):1544-8. PubMed ID: 17556647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene.
    Dörk T; Wulbrand U; Richter T; Neumann T; Wolfes H; Wulf B; Maass G; Tümmler B
    Hum Genet; 1991 Aug; 87(4):441-6. PubMed ID: 1715308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
    Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.